STROKOG (Stroke and Cognition consortium): An international consortium to examine the epidemiology, diagnosis and treatment of neurocognitive disorders in relation to cerebrovascular disease

Perminder S Sachdev; Jessica W.  Lo; John Crawford; Lisa  Mellon; Anne  Hickey; David  Williams; Régis  Bordet; Anne-Marie  Mendyk; Patrick  Gelé; Dominique  Deplanque; Hee-Joon Bae; Jae-Sung  Lim; Amy  Brodtmann; Emilio  Werden; Toby  Cumming; Sebastian  Köhler; Frans R.J.  Verhey; Yan-Hong  Dong; Hui Hui  Tan; Christopher  Chen; Raj N.  Kalaria; Louise M.  Allan; Rufus O.  Akinyemi; Adesola  Ogunniyi; Aleksandra  Klimkowicz-Mrowiec; Martin  Dichgans; Frank A.  Wollenweber; Vera  Zietemann; Michael  Hoffmann; David W.  Desmond; Thomas  Linden; Christian  Blomstrand; Björn  Fagerberg; Ingmar  Skoog; Olivier  Godefroy; Mélanie  Barbay; Martine  Roussel; Byung-Chul  Lee; Kyung-Ho Yu; Joanna Wardlaw; Stephen Makin; Fergus Doubal; Francesca Chappell; Velandai Srikanth; Amanda G Thrift; Geoffrey A Donnan; Naganedran Kandiah; Russell J.  Chander; Xuling  Lin; Charlotte  Cordonnier; Solene  Moulin; Costanza  Rossi; Behnam  Sabayan; David J.  Stott; J. Wouter  Jukema; Susanna  Melkas; Hanna  Jokinen; Timo  Erkinjuntti; Vincent C.T.  Mok; Adrian  Wong; Bonnie Y.K.  Lam; Didier  Leys; Hilde  Hénon; Stéphanie  Bombois; Darren M.  Lipnicki; Nicole A.  Kochan

doi:10.1016/j.dadm.2016.10.006

STROKOG (Stroke and Cognition consortium): An international consortium to examine the epidemiology, diagnosis and treatment of neurocognitive disorders in relation to cerebrovascular disease

Perminder S Sachdev, Jessica W. Lo, John Crawford, Lisa Mellon, Anne Hickey, David Williams, Régis Bordet, Anne-Marie Mendyk, Patrick Gelé, Dominique Deplanque, Hee-Joon Bae, Jae-Sung Lim, Amy Brodtmann, Emilio Werden, Toby Cumming, Sebastian Köhler, Frans R.J. Verhey, Yan-Hong Dong, Hui Hui Tan, Christopher ChenRaj N. Kalaria, Louise M. Allan, Rufus O. Akinyemi, Adesola Ogunniyi, Aleksandra Klimkowicz-Mrowiec, Martin Dichgans, Frank A. Wollenweber, Vera Zietemann, Michael Hoffmann, David W. Desmond, Thomas Linden, Christian Blomstrand, Björn Fagerberg, Ingmar Skoog, Olivier Godefroy, Mélanie Barbay, Martine Roussel, Byung-Chul Lee, Kyung-Ho Yu, Joanna Wardlaw, Stephen Makin, Fergus Doubal, Francesca Chappell, Velandai Srikanth, Amanda G Thrift, Geoffrey A Donnan, Naganedran Kandiah, Russell J. Chander, Xuling Lin, Charlotte Cordonnier, Solene Moulin, Costanza Rossi, Behnam Sabayan, David J. Stott, J. Wouter Jukema, Susanna Melkas, Hanna Jokinen, Timo Erkinjuntti, Vincent C.T. Mok, Adrian Wong, Bonnie Y.K. Lam, Didier Leys, Hilde Hénon, Stéphanie Bombois, Darren M. Lipnicki, Nicole A. Kochan

Research output: Contribution to journal › Article › peer-review

Abstract

Background: The Stroke and Cognition consortium (STROKOG) aims to facilitate a better understanding of the determinants of vascular contributions to cognitive disorders and help improve the diagnosis and treatment of vascular cognitive disorders (VCD).
Methods: Longitudinal studies with ≥ 75 participants who had suffered or were at risk of stroke or TIA, and which evaluated cognitive function were invited to join STROKOG. The consortium will facilitate projects investigating rates and patterns of cognitive decline, risk factors for VCD, and biomarkers of vascular dementia.
Results: Currently STROKOG includes 25 (21 published) studies, with 12,092 participants from 5 continents. The duration of follow up ranges from 3 months to 21 years.
Discussion: While data harmonisation will be a key challenge, STROKOG is in a unique position to reuse and combine international cohort data and fully explore patient level characteristics and outcomes. STROKOG could potentially transform our understanding of VCD and have a worldwide impact on promoting better vascular cognitive outcomes.

Original language	English
Journal	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Early online date	18 Nov 2016
DOIs	https://doi.org/10.1016/j.dadm.2016.10.006
Publication status	E-pub ahead of print - 18 Nov 2016

Access to Document

10.1016/j.dadm.2016.10.006

STROKOG (Stroke and Cognition consortium): An international consortium to examine the epidemiology, diagnosis and treatment of neurocognitive disorders in relation to cerebrovascular disease
This is author's peer-reviewed manuscript as accepted for publication
Accepted author manuscript, 135 KB

http://www.sciencedirect.com/science/article/pii/S2352872916300549

Cite this

Sachdev, P. S., Lo, J. W., Crawford, J., Mellon, L., Hickey, A., Williams, D., Bordet, R., Mendyk, A.-M., Gelé, P., Deplanque, D., Bae, H.-J., Lim, J.-S., Brodtmann, A., Werden, E., Cumming, T., Köhler, S., Verhey, F. R. J., Dong, Y.-H., Tan, H. H., ... Kochan, N. A. (2016). STROKOG (Stroke and Cognition consortium): An international consortium to examine the epidemiology, diagnosis and treatment of neurocognitive disorders in relation to cerebrovascular disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. Advance online publication. https://doi.org/10.1016/j.dadm.2016.10.006

@article{416a3114e3584670979764d0390e9f65,

title = "STROKOG (Stroke and Cognition consortium): An international consortium to examine the epidemiology, diagnosis and treatment of neurocognitive disorders in relation to cerebrovascular disease",

abstract = "Background: The Stroke and Cognition consortium (STROKOG) aims to facilitate a better understanding of the determinants of vascular contributions to cognitive disorders and help improve the diagnosis and treatment of vascular cognitive disorders (VCD).Methods: Longitudinal studies with ≥ 75 participants who had suffered or were at risk of stroke or TIA, and which evaluated cognitive function were invited to join STROKOG. The consortium will facilitate projects investigating rates and patterns of cognitive decline, risk factors for VCD, and biomarkers of vascular dementia. Results: Currently STROKOG includes 25 (21 published) studies, with 12,092 participants from 5 continents. The duration of follow up ranges from 3 months to 21 years. Discussion: While data harmonisation will be a key challenge, STROKOG is in a unique position to reuse and combine international cohort data and fully explore patient level characteristics and outcomes. STROKOG could potentially transform our understanding of VCD and have a worldwide impact on promoting better vascular cognitive outcomes. ",

author = "Sachdev, {Perminder S} and Lo, {Jessica W.} and John Crawford and Lisa Mellon and Anne Hickey and David Williams and R{\'e}gis Bordet and Anne-Marie Mendyk and Patrick Gel{\'e} and Dominique Deplanque and Hee-Joon Bae and Jae-Sung Lim and Amy Brodtmann and Emilio Werden and Toby Cumming and Sebastian K{\"o}hler and Verhey, {Frans R.J.} and Yan-Hong Dong and Tan, {Hui Hui} and Christopher Chen and Kalaria, {Raj N.} and Allan, {Louise M.} and Akinyemi, {Rufus O.} and Adesola Ogunniyi and Aleksandra Klimkowicz-Mrowiec and Martin Dichgans and Wollenweber, {Frank A.} and Vera Zietemann and Michael Hoffmann and Desmond, {David W.} and Thomas Linden and Christian Blomstrand and Bj{\"o}rn Fagerberg and Ingmar Skoog and Olivier Godefroy and M{\'e}lanie Barbay and Martine Roussel and Byung-Chul Lee and Kyung-Ho Yu and Joanna Wardlaw and Stephen Makin and Fergus Doubal and Francesca Chappell and Velandai Srikanth and Thrift, {Amanda G} and Donnan, {Geoffrey A} and Naganedran Kandiah and Chander, {Russell J.} and Xuling Lin and Charlotte Cordonnier and Solene Moulin and Costanza Rossi and Behnam Sabayan and Stott, {David J.} and Jukema, {J. Wouter} and Susanna Melkas and Hanna Jokinen and Timo Erkinjuntti and Mok, {Vincent C.T.} and Adrian Wong and Lam, {Bonnie Y.K.} and Didier Leys and Hilde H{\'e}non and St{\'e}phanie Bombois and Lipnicki, {Darren M.} and Kochan, {Nicole A.}",

year = "2016",

month = nov,

day = "18",

doi = "10.1016/j.dadm.2016.10.006",

language = "English",

journal = "Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring",

issn = "2352-8729",

publisher = "Elsevier",

}

Sachdev, PS, Lo, JW, Crawford, J, Mellon, L, Hickey, A, Williams, D, Bordet, R, Mendyk, A-M, Gelé, P, Deplanque, D, Bae, H-J, Lim, J-S, Brodtmann, A, Werden, E, Cumming, T, Köhler, S, Verhey, FRJ, Dong, Y-H, Tan, HH, Chen, C, Kalaria, RN, Allan, LM, Akinyemi, RO, Ogunniyi, A, Klimkowicz-Mrowiec, A, Dichgans, M, Wollenweber, FA, Zietemann, V, Hoffmann, M, Desmond, DW, Linden, T, Blomstrand, C, Fagerberg, B, Skoog, I, Godefroy, O, Barbay, M, Roussel, M, Lee, B-C, Yu, K-H, Wardlaw, J, Makin, S, Doubal, F , Chappell, F, Srikanth, V, Thrift, AG, Donnan, GA, Kandiah, N, Chander, RJ, Lin, X, Cordonnier, C, Moulin, S, Rossi, C, Sabayan, B, Stott, DJ, Jukema, JW, Melkas, S, Jokinen, H, Erkinjuntti, T, Mok, VCT, Wong, A, Lam, BYK, Leys, D, Hénon, H, Bombois, S, Lipnicki, DM & Kochan, NA 2016, 'STROKOG (Stroke and Cognition consortium): An international consortium to examine the epidemiology, diagnosis and treatment of neurocognitive disorders in relation to cerebrovascular disease', Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. https://doi.org/10.1016/j.dadm.2016.10.006

STROKOG (Stroke and Cognition consortium): An international consortium to examine the epidemiology, diagnosis and treatment of neurocognitive disorders in relation to cerebrovascular disease. / Sachdev, Perminder S; Lo, Jessica W. ; Crawford, John et al.
In: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18.11.2016.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - STROKOG (Stroke and Cognition consortium): An international consortium to examine the epidemiology, diagnosis and treatment of neurocognitive disorders in relation to cerebrovascular disease

AU - Sachdev, Perminder S

AU - Lo, Jessica W.

AU - Crawford, John

AU - Mellon, Lisa

AU - Hickey, Anne

AU - Williams, David

AU - Bordet, Régis

AU - Mendyk, Anne-Marie

AU - Gelé, Patrick

AU - Deplanque, Dominique

AU - Bae, Hee-Joon

AU - Lim, Jae-Sung

AU - Brodtmann, Amy

AU - Werden, Emilio

AU - Cumming, Toby

AU - Köhler, Sebastian

AU - Verhey, Frans R.J.

AU - Dong, Yan-Hong

AU - Tan, Hui Hui

AU - Chen, Christopher

AU - Kalaria, Raj N.

AU - Allan, Louise M.

AU - Akinyemi, Rufus O.

AU - Ogunniyi, Adesola

AU - Klimkowicz-Mrowiec, Aleksandra

AU - Dichgans, Martin

AU - Wollenweber, Frank A.

AU - Zietemann, Vera

AU - Hoffmann, Michael

AU - Desmond, David W.

AU - Linden, Thomas

AU - Blomstrand, Christian

AU - Fagerberg, Björn

AU - Skoog, Ingmar

AU - Godefroy, Olivier

AU - Barbay, Mélanie

AU - Roussel, Martine

AU - Lee, Byung-Chul

AU - Yu, Kyung-Ho

AU - Wardlaw, Joanna

AU - Makin, Stephen

AU - Doubal, Fergus

AU - Chappell, Francesca

AU - Srikanth, Velandai

AU - Thrift, Amanda G

AU - Donnan, Geoffrey A

AU - Kandiah, Naganedran

AU - Chander, Russell J.

AU - Lin, Xuling

AU - Cordonnier, Charlotte

AU - Moulin, Solene

AU - Rossi, Costanza

AU - Sabayan, Behnam

AU - Stott, David J.

AU - Jukema, J. Wouter

AU - Melkas, Susanna

AU - Jokinen, Hanna

AU - Erkinjuntti, Timo

AU - Mok, Vincent C.T.

AU - Wong, Adrian

AU - Lam, Bonnie Y.K.

AU - Leys, Didier

AU - Hénon, Hilde

AU - Bombois, Stéphanie

AU - Lipnicki, Darren M.

AU - Kochan, Nicole A.

PY - 2016/11/18

Y1 - 2016/11/18

N2 - Background: The Stroke and Cognition consortium (STROKOG) aims to facilitate a better understanding of the determinants of vascular contributions to cognitive disorders and help improve the diagnosis and treatment of vascular cognitive disorders (VCD).Methods: Longitudinal studies with ≥ 75 participants who had suffered or were at risk of stroke or TIA, and which evaluated cognitive function were invited to join STROKOG. The consortium will facilitate projects investigating rates and patterns of cognitive decline, risk factors for VCD, and biomarkers of vascular dementia. Results: Currently STROKOG includes 25 (21 published) studies, with 12,092 participants from 5 continents. The duration of follow up ranges from 3 months to 21 years. Discussion: While data harmonisation will be a key challenge, STROKOG is in a unique position to reuse and combine international cohort data and fully explore patient level characteristics and outcomes. STROKOG could potentially transform our understanding of VCD and have a worldwide impact on promoting better vascular cognitive outcomes.

AB - Background: The Stroke and Cognition consortium (STROKOG) aims to facilitate a better understanding of the determinants of vascular contributions to cognitive disorders and help improve the diagnosis and treatment of vascular cognitive disorders (VCD).Methods: Longitudinal studies with ≥ 75 participants who had suffered or were at risk of stroke or TIA, and which evaluated cognitive function were invited to join STROKOG. The consortium will facilitate projects investigating rates and patterns of cognitive decline, risk factors for VCD, and biomarkers of vascular dementia. Results: Currently STROKOG includes 25 (21 published) studies, with 12,092 participants from 5 continents. The duration of follow up ranges from 3 months to 21 years. Discussion: While data harmonisation will be a key challenge, STROKOG is in a unique position to reuse and combine international cohort data and fully explore patient level characteristics and outcomes. STROKOG could potentially transform our understanding of VCD and have a worldwide impact on promoting better vascular cognitive outcomes.

U2 - 10.1016/j.dadm.2016.10.006

DO - 10.1016/j.dadm.2016.10.006

M3 - Article

SN - 2352-8729

JO - Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

JF - Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

ER -

Sachdev PS, Lo JW, Crawford J, Mellon L, Hickey A, Williams D et al. STROKOG (Stroke and Cognition consortium): An international consortium to examine the epidemiology, diagnosis and treatment of neurocognitive disorders in relation to cerebrovascular disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2016 Nov 18. Epub 2016 Nov 18. doi: 10.1016/j.dadm.2016.10.006

STROKOG (Stroke and Cognition consortium): An international consortium to examine the epidemiology, diagnosis and treatment of neurocognitive disorders in relation to cerebrovascular disease

Abstract

Access to Document

Fingerprint

Cite this